Skip to content

AGIOS PHARMACEUTICALS, INC.: filings

Every AGIOS PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 53 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-07-30fiscal Q2 2026391090001439222-26-000118
10-Q2026-04-29fiscal Q1 202639810001439222-26-000073
10-K2026-02-12fiscal FY 2025441150001439222-26-000025
10-Q2025-10-30fiscal Q3 2025411210001439222-25-000116
10-Q2025-07-31fiscal Q2 2025391090001439222-25-000089
10-Q2025-05-01fiscal Q1 202539810001439222-25-000036
10-K2025-02-13fiscal FY 2024431120001439222-25-000009
10-Q2024-10-31fiscal Q3 2024411210001439222-24-000138
10-Q2024-08-01fiscal Q2 2024391090001439222-24-000121
10-Q2024-05-02fiscal Q1 202439810001439222-24-000069
10-K2024-02-15fiscal FY 2023421090001439222-24-000035
10-Q2023-11-02fiscal Q3 2023381110001439222-23-000140
10-Q2023-08-03fiscal Q2 2023381070001439222-23-000119
10-Q2023-05-04fiscal Q1 202338790001439222-23-000065
10-K2023-02-23fiscal FY 2022421090001439222-23-000039
10-Q2022-11-03fiscal Q3 2022401170001439222-22-000099
10-Q2022-08-04fiscal Q2 2022401130001439222-22-000070
10-Q2022-05-05fiscal Q1 202238790001439222-22-000040
10-K2022-02-24fiscal FY 2021391300001439222-22-000024
10-Q2021-11-03fiscal Q3 2021351050001439222-21-000073
10-Q2021-07-29fiscal Q2 2021351010001439222-21-000064
10-Q2021-04-29fiscal Q1 202132670001439222-21-000040
10-K2021-02-25fiscal FY 2020381230001439222-21-000029
10-Q2020-11-05fiscal Q3 202032890001439222-20-000069
10-Q2020-07-30fiscal Q2 202033870001439222-20-000059
10-Q2020-04-30fiscal Q1 202033690001439222-20-000039
10-K2020-02-19fiscal FY 2019401210001439222-20-000014
10-Q2019-10-31fiscal Q3 201935940001439222-19-000021
10-Q2019-08-01fiscal Q2 201935900001439222-19-000017
10-Q2019-05-02fiscal Q1 201935710001439222-19-000009
10-K2019-02-14fiscal FY 2018361150001439222-19-000004
10-Q2018-11-01fiscal Q3 201831800001439222-18-000018
10-Q2018-08-02fiscal Q2 201828740001439222-18-000014
10-Q2018-05-04fiscal Q1 201828600001439222-18-000009
10-K2018-02-14fiscal FY 2017321070001439222-18-000004
10-Q2017-11-01fiscal Q3 201728730001439222-17-000009
10-Q2017-08-08fiscal Q2 201728730001439222-17-000007
10-Q2017-05-04fiscal Q1 201723490001193125-17-157874
10-K2017-02-16fiscal FY 201632980001193125-17-046795
10-Q2016-11-03fiscal Q3 201624630001193125-16-758835
10-Q2016-08-08fiscal Q2 201623600001193125-16-675231
10-Q2016-05-09fiscal Q1 201623480001193125-16-582822
10-K2016-02-26fiscal FY 2015331070001193125-16-481973
10-Q2015-11-06fiscal Q3 201529860001193125-15-370225
10-Q2015-08-07fiscal Q2 201523620001193125-15-283076
10-Q2015-05-11fiscal Q1 201523480001193125-15-181968
10-K2015-02-24fiscal FY 2014351240001193125-15-060046
10-Q2014-11-07fiscal Q3 201432930001193125-14-403316
10-Q2014-08-07fiscal Q2 201429770001193125-14-300949
10-Q2014-05-09fiscal Q1 201428560001193125-14-192411
10-K2014-03-18fiscal FY 2013341230001193125-14-104521
10-Q2013-11-07fiscal Q3 201333900001193125-13-433119
10-Q2013-09-05fiscal Q2 201332880001193125-13-358412

Inspect the source

Entity
AGIOS PHARMACEUTICALS, INC. / CIK 0001439222
Captured
2026-09-20T09:03:55.707Z
SEC response SHA-256
645ad0ff8d5c2720a304e1acd1f7ac20706112192f830d9a1be52e84493b37d5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001439222.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))